Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Clinical trial NCT00237523 · UNKNOWN

Trial details

NCT number: NCT00237523
Sponsor: Symbollon Pharmaceuticals
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Fibrocystic Disease of Breast Fibrocystic Changes of Breast Fibrocystic Mastopathy Pain

Start date: 2005-07-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.